AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline
Summary
The drugmaker expects one-time restructuring costs of up to $2 billion as it redeploys resources over three years
Description from Quartz.
Who is covering this
-
AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline
The drugmaker expects one-time restructuring costs of up to $2 billion as it redeploys resources over three years
